Global Aquaculture Vaccines Market
Global Aquaculture Vaccines Market Worth $412M in 2023 Will Reach $1B by 2034 - Key Insights by Product, Route of Administration, Application and Region
March 13, 2024 11:24 ET | Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global Aquaculture Vaccines Market Analysis & Forecast to 2024-2034: Market By Product; By Route Of Administration; By Application; and By Region"...
22157.jpg
Global Syndromic Multiplex Panels Market Set for Rapid Expansion, Reveals New 2024-2028 Sector Forecast
March 12, 2024 11:23 ET | Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country....
Global BCG Vaccine Market
Global BCG Vaccine Market to Showcase 5.47% CAGR Through 2034, Driven by Advancements and Global Tuberculosis Burden - Trends and Insights by Age Group, Application, Distribution Channel, and Region
March 11, 2024 14:16 ET | Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global BCG Vaccine Market by Age Group, Application, Distribution Channel, and By Region" report has been added to ResearchAndMarkets.com's offering....
Global Brucellosis Vaccine Market
Global Brucellosis Vaccine Market Worth $421 Million by 2034 - Subunit Vaccines Lead Innovation as DNA Vaccines Gain Momentum, Cattle Segment Dominates with Rapid Growth Expected in Small Ruminants
March 11, 2024 13:49 ET | Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global Brucellosis Vaccine Market by Vaccine Type, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's...
Global Anthrax Vaccine Market
Global Anthrax Vaccine Market Worth Over $22 Billion by 2034, Driven by Advanced Vaccine Developments and Rising Demand for Bioterrorism Defense
March 11, 2024 13:32 ET | Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global Anthrax Vaccine Market by Vaccine Type, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's...
22157.jpg
Vaccine Research Report 2024: Global Trends, Opportunities and Competitive Analysis to 2030 Featuring GlaxoSmithKline, Merck, Pfizer, Sanofi, and CSL
March 11, 2024 11:26 ET | Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Market: Trends, Opportunities and Competitive Analysis [2024-2030]" report has been added to ResearchAndMarkets.com's offering.The global...
22157.jpg
Asia Pacific Point Of Care Diagnostics Market Forecasted to Surge, Reaching USD 15.61 Billion by 2030 with a CAGR of 8.1%
March 06, 2024 10:30 ET | Research and Markets
Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Asia Pacific Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac...
22157.jpg
mRNA Vaccines in the Global Infectious Diseases Market: Opportunities, Challenges, Unmet Needs, Current Companies and Market Outlook
March 04, 2024 11:54 ET | Research and Markets
Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "mRNA Vaccines in Infectious Diseases Market Overview" report has been added to ResearchAndMarkets.com's offering.The report provides an assessment of...
22157.jpg
Europe Multicancer Screening Market Analysis and Forecasts, 2023-2024 and 2032 - Robust Pipeline of Multicancer Screening Tests Poised to Revolutionize Cancer Diagnosis
February 29, 2024 10:26 ET | Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Europe Multicancer Screening Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The Europe...
22157.jpg
World Home Diagnostics Markets, Strategies, Trends and Forecasts Report 2024 Market Analysis and Executive Guides
February 29, 2024 07:33 ET | Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Home Diagnostics Markets. Strategies and Trends. Forecasts by Application by Channel by Technology and by Country. With Market Analysis and Executive...